Sumerax Life Science Private Limited
About Sumerax Life Science Private Limited
Data last updated:
Sumerax Life Science Private Limited is a private limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 16 May 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24230DL2019PTC350127. Its GSTIN is 10ABCCS0683H1ZO (Bihar).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Arvind Jain and Abhishek Jain.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at G – 83 Office No. 204 Second Floor Laxmi Nagar, Delhi, India – 110092.
As per the financials filed for FY 2024, the company reported a revenue of ₹2.99 Cr, a growth of 41% compared to the previous year. For the same year it recorded a net profit of ₹11.21 Lakh (net margin 3.7%) and EBITDA of ₹15.26 Lakh (EBITDA margin 5.1%).
Company details
Contact details
Sumerax Life Science Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressG – 83 Office No. 204 Second Floor Laxmi Nagar, Delhi, India – 110092
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Sumerax Life Science Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Sumerax Life Science is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Sumerax Life Science Private Limited, buy the company report.
Financials of Sumerax Life Science Private Limited
FY 2024 filings availableSumerax Life Science Private Limited reported revenue of ₹2.99 Cr (up 41% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 41% in the latest year. EBITDA rose 52% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹15.26 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹11.21 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.1% | ||||
| Net Profit Margin | 3.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sumerax Life Science Private Limited, buy the company report.
Board of directors of Sumerax Life Science Private Limited
Sumerax Life Science has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Arvind Jain Also directs: Vinayakia Academy Private Limited | Director | 16 May 2019 | 7 Years 5 Months | Current |
| Abhishek Jain | Director | 16 May 2019 | 7 Years 5 Months | Current |
Auditor
Sumerax Life Science Private Limited is audited by SANJAY GULAB & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SANJAY GULAB & CO. | FY 2023 | 012598N |
Shareholding
The shareholding of Sumerax Life Science Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Sumerax Life Science Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Sumerax Life Science Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sumerax Life Science Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Sumerax Life Science has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10ABCCS0683H1ZO | Bihar | Active | 23 Feb 2021 |
To see the full GST registrations and return filing status of Sumerax Life Science Private Limited, buy the company report.
Recent activity
Sumerax Life Science Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Abhishek Jain was appointed as Director on 16 May 2019.
Frequently asked questions
Sumerax Life Science is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 16 May 2019 (7+ years old) and is registered under CIN U24230DL2019PTC350127.
Sumerax Life Science has 2 current directors:
- Arvind Jain - Director
- Abhishek Jain - Director
The latest financial statements of Sumerax Life Science on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Sumerax Life Science is 10ABCCS0683H1ZO, registered in Bihar.
The CIN (Corporate Identification Number) of Sumerax Life Science is U24230DL2019PTC350127. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sumerax Life Science was incorporated on 16 May 2019, making it 7+ years old. It is registered with the Registrar of Companies, Delhi.
Abhishek Jain was appointed as Director on 16 May 2019. Arvind Jain was appointed as Director on 16 May 2019.
The registered office of Sumerax Life Science is at G – 83 Office No. 204 Second Floor Laxmi Nagar, Delhi, India – 110092.
Sumerax Life Science operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Sumerax Life Science can be reached at its registered office: G – 83 Office No. 204 Second Floor Laxmi Nagar, Delhi, India – 110092.